Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mueller

Showing results (461-470 of 688) with videos related to

Pageof 69
Sort By:
Frontiers in Neurology|January 8, 2013
The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant EpilepsyJohn R Pollard, Ofer Eidelman, Gregory P Mueller, et al.
Annals of Surgical Oncology|November 15, 2006
Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancerKlaus L Prenzel, Alexandra König, Paul M Schneider, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1996
Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy aloneE Dühmke, V Diehl, M Loeffler, et al.
Frontiers in Neurology|April 15, 2015
Multivariate analysis of traumatic brain injury: development of an assessment scoreJohn E Buonora, Angela M Yarnell, Rachel C Lazarus, et al.
Pulmonology|February 6, 2021
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsD Visca, C W M Ong, S Tiberi, et al.
Journal of Hepatology|February 14, 2022
Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradicationPeter P Mueller, Qiushi Chen, Turgay Ayer, et al.
American Journal of Industrial Medicine|January 9, 2001
Health effects of long-term mercury exposure among chloralkali plant workersH Frumkin, R Letz, P L Williams, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbamCraig J McPherson, Lisa M Aschenbrenner, Brian M Lacey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1S J Faas, M A Giannoni, A P Mickle, et al.
Transplantation|December 1, 1989
Local immunosuppression with reduced systemic toxicity in a canine renal allograft modelS A Gruber, W J Hrushesky, R J Cipolle, et al.
Pageof 69

Showing results (461-470 of 688) with videos related to

Sort By:
Pageof 69
Frontiers in Neurology|January 8, 2013
The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant EpilepsyJohn R Pollard, Ofer Eidelman, Gregory P Mueller, et al.
Annals of Surgical Oncology|November 15, 2006
Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancerKlaus L Prenzel, Alexandra König, Paul M Schneider, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1996
Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy aloneE Dühmke, V Diehl, M Loeffler, et al.
Frontiers in Neurology|April 15, 2015
Multivariate analysis of traumatic brain injury: development of an assessment scoreJohn E Buonora, Angela M Yarnell, Rachel C Lazarus, et al.
Pulmonology|February 6, 2021
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsD Visca, C W M Ong, S Tiberi, et al.
Journal of Hepatology|February 14, 2022
Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradicationPeter P Mueller, Qiushi Chen, Turgay Ayer, et al.
American Journal of Industrial Medicine|January 9, 2001
Health effects of long-term mercury exposure among chloralkali plant workersH Frumkin, R Letz, P L Williams, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbamCraig J McPherson, Lisa M Aschenbrenner, Brian M Lacey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1S J Faas, M A Giannoni, A P Mickle, et al.
Transplantation|December 1, 1989
Local immunosuppression with reduced systemic toxicity in a canine renal allograft modelS A Gruber, W J Hrushesky, R J Cipolle, et al.
Pageof 69